Published in Med J Aust on January 04, 1993
Use of sequential case-control studies to investigate a community Salmonella outbreak in Wales. J Epidemiol Community Health (1998) 0.76
L-tryptophan and eosinophilia-myalgia syndrome. Med J Aust (1993) 0.75
Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA (1996) 2.67
Use of antiasthmatic drugs in Australia. Med J Aust (1990) 2.47
Smoking as a risk factor for cerebral ischaemia. Lancet (1989) 2.26
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ (1994) 2.25
Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med (2001) 2.19
Why older patients of lower clinical urgency choose to attend the emergency department. Intern Med J (2013) 2.19
The effects of bonus payments on emergency service performance in Victoria. Med J Aust (1999) 2.16
PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998. Med J Aust (2001) 2.15
Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J Am Coll Cardiol (1999) 2.09
Trials of streptokinase in severe acute ischaemic stroke. Lancet (1995) 1.98
Risk factors for lacunar infarction syndromes. Neurology (1995) 1.97
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ (1995) 1.70
Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke (2001) 1.69
Maxillofacial trauma in major trauma patients. Aust Dent J (2006) 1.68
Pharmacokinetics of the H2- receptor antagonist ranitidine in man. Br J Clin Pharmacol (1981) 1.67
Linking prescription and patient-identifying data: a pilot study. Med J Aust (1992) 1.48
Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2000) 1.48
The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly) J Am Geriatr Soc (1994) 1.45
Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis (1992) 1.44
Out-of-hospital cardiac arrest. Med J Aust (2000) 1.42
Asystolic cardiac arrest in Melbourne, Australia. Emerg Med (Fremantle) (2001) 1.41
Should smoking be an indication for lipid-lowering therapy? Med J Aust (1999) 1.40
Cardiac risk factor management. Experience of an outpatient hypertension clinic. Med J Aust (1991) 1.40
Australians with renal disease: a new national survey. Med J Aust (1999) 1.38
Hypertension and stroke. J Hypertens (1994) 1.38
Trends in prescribing of antihypertensive drugs in Australia, 1977-1987. Med J Aust (1990) 1.38
Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2001) 1.36
Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health (1999) 1.34
Informal care for stroke survivors: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2002) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience. J Clin Epidemiol (2000) 1.30
Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer (1997) 1.26
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol (1979) 1.23
Interrater reliability of the National Institutes of Health Stroke Scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis (1999) 1.21
Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis (2005) 1.17
An evaluation of laparoscopic versus open cholecystectomy. Med J Aust (1994) 1.16
Monitoring chemical exposure using breast milk: a methodological review. Am J Epidemiol (1992) 1.15
A randomized controlled clinical trial of pharmacokinetic theophylline dosing. Am Rev Respir Dis (1986) 1.13
Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther (1993) 1.12
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Br J Clin Pharmacol (1979) 1.10
Traumatic pneumobilia: case report. J Trauma (2001) 1.10
Risk factors for stroke due to cerebral infarction in young adults. Stroke (1997) 1.08
Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke (1996) 1.08
Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol (1993) 1.07
Trends in Australian mortality of asthma, 1979-1985. Med J Aust (1989) 1.06
Risk factors for cardiovascular disease in chronic spinal cord injury patients. Paraplegia (1992) 1.04
Risk factors for development of flucloxacillin associated jaundice. BMJ (1993) 1.04
Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension (1998) 1.04
Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer (1994) 1.03
Drug doping in senior Australian rules football: a survey for frequency. Br J Sports Med (1997) 1.03
How safe are beta-blocking drugs? Med J Aust (1977) 1.01
Antismoking products. Med J Aust (1991) 1.01
Epidemiology of intracerebral hemorrhage. Epidemiol Rev (1995) 1.01
Methods for detecting age-related maculopathy: a comparison between photographic and clinical assessment. Clin Experiment Ophthalmol (2000) 1.00
Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic. Am J Hosp Pharm (1988) 0.99
Results from the first 12 months of a fire first-responder program in Australia. Resuscitation (2001) 0.97
Effect of age on pharmacokinetics of and blood pressure responses to prazosin and terazosin. J Cardiovasc Pharmacol (1987) 0.92
Comparison of recruitment strategies for a large-scale clinical trial in the elderly. J Clin Epidemiol (1991) 0.92
The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry. Lung (2014) 0.91
Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria. Med J Aust (2001) 0.90
Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health (1996) 0.90
The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol (1994) 0.90
Herbal preparations--to regulate or not to regulate? Med J Aust (1989) 0.90
Pharmacokinetic and gastric secretory studies of ranitidine in man. Scand J Gastroenterol Suppl (1981) 0.89
Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ (1999) 0.89
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens (1997) 0.89
Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin Exp Pharmacol Physiol (1997) 0.88
Respiratory symptoms and lung function in bauxite miners. Int Arch Occup Environ Health (2001) 0.87
The risk of intracerebral haemorrhage with smoking. The Melbourne Risk Factor Study Group. Cerebrovasc Dis (1999) 0.87
Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke. Am J Cardiol (1996) 0.87
Methicillin-resistant Staphylococcus aureus in an Australian teaching hospital. J Hosp Infect (1984) 0.87
Orthopaedic trauma: establishment of an outcomes registry to evaluate and monitor treatment effectiveness. Injury (2005) 0.86
Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment. Eur J Clin Pharmacol (1997) 0.86
Characterisation of orthopaedic trauma admitted to adult level 1 trauma centres. Injury (2006) 0.86
Respiratory symptoms and lung function in alumina refinery employees. Occup Environ Med (2000) 0.85
Clinical pharmacology of adrenergic-blocking drugs. Cardiology (1979) 0.85
Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects. J Cardiovasc Pharmacol (1992) 0.85
Comparison of clinical and digital assessment of nuclear optical density. Ophthalmic Res (1999) 0.85
Smoking as a risk factor for cortical ischaemia presumably due to carotid occlusive disease. Neuroepidemiology (1993) 0.85
Survey of drug-related deaths in Victoria. Med J Aust (1992) 0.85
Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol (2000) 0.84
Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate. Eur J Clin Pharmacol (1989) 0.84
The role of past intake of vitamin E in early cataract changes. Ophthalmic Epidemiol (1999) 0.84
Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients. Intern Med J (2003) 0.84
Comparison of metoprolol and pindolol in the treatment of mild to moderate hypertension: a double-blind crossover study. Med J Aust (1979) 0.83
Heavy drinking, but not moderate or intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology (1999) 0.83
Predictors and timing of adverse experiences during trandsdermal nicotine therapy. Drug Saf (1999) 0.83
Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. Ophthalmic Epidemiol (1999) 0.83
Comparison of felodipine extended release and conventional tablets in essential hypertension using ambulatory blood pressure monitoring. J Hypertens (1989) 0.83
A pharmacokinetic study of carvedilol (BM 14.190) in elderly subjects: preliminary report. J Cardiovasc Pharmacol (1987) 0.82
Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study. Aust N Z J Ophthalmol (1999) 0.82
Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust (1995) 0.82
Discordance of mercury sphygmomanometer and ambulatory blood pressure measurements for the detection of untreated hypertension in a population study. J Hum Hypertens (1993) 0.81
Streptokinase in acute ischaemic stroke. Steering Committees of the ASK and MAST-E trials. Australian Streptokinase Trial. Lancet (1995) 0.80
Spectrum of proteinuria in type I and type II diabetes. Diabetes Care (1987) 0.80
An analysis of the blood pressure response to labetalol in hypertensive patients. Clin Sci (Lond) (1981) 0.80
Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity. Br J Clin Pharmacol (1982) 0.80
Internal mammary artery grafting: is this a benign procedure? J Cardiovasc Surg (Torino) (1989) 0.80
Advance directives and emergency department patients: ownership rates and perceptions of use. Intern Med J (2003) 0.80
Is the public equipped to act in out of hospital cardiac emergencies? Emerg Med J (2003) 0.79